
LMP1 is an Epstein-Barr virus protein that has a "Mr. Hyde" side that can promote cancer and a "Dr. Jekyll" side that can spur antitumor immune responses. Scientists at Hiroshima University have now traced key antitumor immune effects of LMP1 to two transcription factors, Spi-B and IRF1, and found that expressing the two together made tumor cells easier for the immune system to recognize and better able to activate CD8+ T cells without using the viral protein itself.
Continue to Phys.org →You are being forwarded in 6s — stay on this page